Roche AG has become the latest pharmaceutical company to respond to the Trump administration’s threat to impose tariffs, saying it will invest $50 billion in drug and diagnostics manufacturing in the ...

Invivyd secures $30M loan facility from Silicon Valley Bank in three $10M tranches, ahead of FDA discussions about Covid-19 antibody VYD2311 ...

H.C. Wainwright lowered the firm’s price target on Alumis (ALMS) to $14 from $15 and keeps a Buy rating on the shares. The firm cites ...

An ivonescimab-chemotherapy combination succeeded in a study in China. Elsewhere, the FDA asked Novavax for more COVID vaccine data and Regeneron boosted its manufacturing capabilities.

Alumis (NASDAQ:ALMS) and ACELYRIN (NASDAQ:SLRN) have updated their merger agreement, which now specifies new terms for the ...

The webcast will be hosted by Greg Reid, President and CEO and Joe Mackay, CFO of Kraken Robotics and will cover fourth ...

Alumis (ALMS) and Acelyrin (SLRN) announced an amendment to the existing terms of their previously announced merger agreement: Acelyrin ...

ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximate ...

In this video, Raj Chovatiya, MD, PhD, discusses findings from the phase 2 STRIDE trial presented at this year’s American ...

SLRN)'s sale to Alumis Inc. for 0.4274 shares of Alumis common stock for each share of ACELYRIN common stock. If you are an ACELYRIN shareholder, click here to learn more about your legal rights and ...

A Peninsula biotech startup's acquisition of a Chicago health data firm could transform how heart drugs are developed, ...